GlobeNewsWire
07 Jul 2026, 20:50 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
ADMA Biologics is facing a class action lawsuit alleging the use of channel stuffing and undisclosed related party transactions to inflate reported revenue. — Allegations of accounting fraud and revenue manipulation are severe red flags that typically lead to significant valuation write-downs and loss of investor trust.
-0.80Culper Research issued a report claiming ADMA's reported 20% growth was a fiction and that real growth in 2025 was actually -3%. — A massive discrepancy between reported and real growth directly undermines the company's fundamental investment thesis.
-0.70Cantor Fitzgerald downgraded ADMA Biologics from Overweight to Neutral following the short-seller report and the company's response. — A downgrade from a major institutional analyst signals a shift in professional sentiment and often triggers further selling pressure.
-0.50Continue reading
6 related stories
Top 3 movers · tap to explore
The lawsuit alleges that ADMA Biologics lacked adequate internal controls during the class period between August 9, 2024, and March 25, 2026. — Failure of internal controls suggests systemic operational risks and increases the likelihood that the fraud allegations are substantiated.
-0.40Which stocks this story touches
The company is facing a shareholder class action lawsuit alleging fraud, channel stuffing, and internal control failures.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
1h ago
